APO-RIVASTIGMINE PATCH 10 rivastigmine 9.5 mg/24 hours transdermal drug delivery system sachet

Land: Australien

Sprog: engelsk

Kilde: Department of Health (Therapeutic Goods Administration)

Aktiv bestanddel:

rivastigmine, Quantity: 18 mg

Tilgængelig fra:

Arrotex Pharmaceuticals Pty Ltd

INN (International Name):

Rivastigmine

Lægemiddelform:

Drug delivery system, transdermal

Sammensætning:

Excipient Ingredients: acrylates copolymer; ethyl acetate; methylated trimethylated silica; hexane; 2-ethylhexyl acrylate; methyl acrylate; acrylic acid; acrylates/ethylhexyl acrylate copolymer

Indgivelsesvej:

Transdermal

Enheder i pakken:

7 transdermal drug delivery systems, 30 transdermal drug delivery systems

Recept type:

(S4) Prescription Only Medicine

Terapeutiske indikationer:

APO-RIVASTIGMINE is indicated for the treatment of patients with mild to moderate dementia of the Alzheimer's type.

Produkt oversigt:

Visual Identification: Circular 10cm2 transdermal patch, tri-layer adhesive matrix, translucent white backing film labelled with "Rivastigmine 9.5 mg/24 h"; Container Type: Sachet; Container Material: Other composite material; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Autorisation status:

Licence status A

Autorisation dato:

2016-01-12